To Amend The Law Concerning Health-related Cash Discount Cards.
HB1473 amends Arkansas law governing health-related cash discount cards, which are products that are not insurance but purport to offer discounts or access to discounts from healthcare providers in exchange for fees or dues. The bill tightens disclosure and marketing requirements by requiring these cards and related advertisements to clearly state, in bold and prominent language, that the product is not insurance and that consumers have a 30-day right to cancel. It also requires that any discounts be specifically authorized by separate contracts with each listed healthcare provider and prohibits misleading, deceptive, or fraudulent representations, including the use of insurance-like terms such as “health plan,” “preexisting condition,” or “coverage” in a way that could confuse consumers.
The bill also strengthens enforcement and remedies. It expands the ability of the Attorney General, consumers, businesses, municipalities, and trade associations to sue for injunctions and damages, sets venue options for actions, and establishes statutory damages of the greater of $100 per card or device sold in Arkansas or $10,000, plus treble actual damages, attorney’s fees, costs, and other relief. It adds a two-year limitations period, allows a 180-day extension in cases of concealment, and creates a 30-day pre-suit notice-and-cure process for consumer damages claims. The act is also made retroactive to alleged violations occurring before its effective date.
The overall sentiment appears protective of consumers and skeptical of potentially misleading health discount products, though no committee testimony or votes are available in the provided record. The bill’s structure suggests a policy goal of preventing these products from being marketed as if they were insurance and of giving consumers stronger tools to challenge deceptive practices. Because there is no recorded debate or vote history here, there is no direct evidence of support or opposition from legislators or stakeholders in the available materials.
The main point of contention likely concerns the breadth of the enforcement provisions and the retroactive application. Businesses that market discount cards may view the enhanced statutory damages, expanded standing to sue, and retroactivity as burdensome or punitive, while consumer advocates would likely support the clearer disclosures and stronger remedies. Another possible issue is the requirement for separate provider contracts and the prohibition on insurance-like terminology, which could affect how discount-card programs are structured and advertised in Arkansas.
HB1473 would amend Arkansas Code §§ 4-106-201 and 4-106-202 to impose stricter disclosure, advertising, and contracting rules on health-related cash discount cards and similar non-insurance purchasing mechanisms. It would also expand civil enforcement, increase potential damages and penalties, add a notice-and-cure process for consumer suits, and make the changes apply retroactively to alleged prior violations. The bill primarily affects discount-card vendors, healthcare provider networks, consumers, and the Attorney General’s enforcement authority, while leaving the Deceptive Trade Practices Act and other remedies intact as cumulative options.
Based on the bill text, the measure is framed as a consumer-protection and anti-deception bill aimed at preventing confusion between discount cards and insurance. No committee discussion or voting history is provided, so there is no recorded legislative sentiment to summarize beyond the bill’s apparent protective intent. The absence of debate records means support or opposition from specific lawmakers or stakeholders cannot be confirmed from the available materials.
The likely controversy centers on whether the bill’s enforcement scheme is proportionate. Potential opponents may object to the statutory damages, treble damages, broad standing to sue, and retroactive application, arguing these provisions could expose businesses to significant liability. Supporters would likely emphasize the need for clear disclosures, cancellation rights, and stronger remedies to stop misleading marketing of health-related discount products. The requirement for separate contracts with each healthcare provider and the ban on insurance-associated terminology may also be contentious because they could limit how these products are sold and advertised.